Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension

Figure 9

Cumulative % drug release of Nebivolol and Nateglinide bilayer tablet.